Results 1 to 10 of about 18,544,591 (363)

The prevalence and types of discordance between physician perception and objective data from standardized measures of rheumatoid arthritis disease activity in real-world clinical practice in the US

open access: yesBMC Rheumatology, 2019
Background Heterogeneity in assessments of rheumatoid arthritis (RA) disease remission, based on physician judgment and patient self-reports versus standardized measures, have previously been reported.
Wenhui Wei   +5 more
doaj   +1 more source

Patient-reported outcomes and healthcare resource utilization in systemic lupus erythematosus: impact of disease activity

open access: yesBMC Rheumatology
Background Limited real-world data exists on clinical outcomes in systemic lupus erythematosus (SLE) patients by SLE Disease Activity Index 2000 (SLEDAI-2 K), hereafter, SLEDAI.
Zahi Touma   +7 more
doaj   +1 more source

Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage

open access: yesBMC Cancer, 2019
Background Although evidence suggests that stage of disease may influence costs associated with non-small cell lung cancer (NSCLC), there remains a relative paucity of data on the financial burden incurred directly by patients and their informal ...
Robert Wood, Gavin Taylor-Stokes
doaj   +1 more source

YOLO-World: Real-Time Open-Vocabulary Object Detection [PDF]

open access: yesComputer Vision and Pattern Recognition
The You Only Look Once (YOLO) series of detectors have established themselves as efficient and practical tools. However, their reliance on predefined and trained object categories limits their applicability in open scenarios.
Tianheng Cheng   +5 more
semanticscholar   +1 more source

Burden of metabolic dysfunction-associated steatohepatitis, with and without metabolic syndrome, obesity, or diabetes

open access: yesBMC Gastroenterology
Background Metabolic dysfunction-associated steatohepatitis (MASH) is commonly comorbid with metabolic syndrome; however, MASH can occur in the absence of metabolic syndrome.
Elliot B. Tapper   +5 more
doaj   +1 more source

Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B2-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study

open access: yesBMJ Open
Objective Management of chronic obstructive pulmonary disease (COPD) with inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) improves lung function and health status and reduces COPD exacerbation risk versus monotherapy.
Victoria Banks   +7 more
doaj   +1 more source

The use of triptans and other acute treatments for the management of migraine in routine clinical practice in England: a retrospective cohort study using the Clinical Practice Research Datalink (CPRD)

open access: yesBMC Primary Care
Background Migraine is a common and disabling neurological condition affecting around 10 million people in the UK. Optimal management has been indicated as a priority for improving migraine care in the UK, supported by clinical guidelines to provide ...
Shuk-Li Collings   +7 more
doaj   +1 more source

Evaluating the Effectiveness of 2024–2025 Seasonal mRNA-1273 Vaccination Against COVID-19-Related Hospitalizations and Medically Attended COVID-19 Among Adults Aged ≥ 18 years in the United States: An Observational Matched Cohort Study

open access: yesInfectious Diseases and Therapy
Introduction This study evaluated the effectiveness of Moderna’s updated mRNA-1273 vaccine targeting the KP.2 variant, compared to people who did not receive any 2024–2025 COVID-19 vaccine, in preventing COVID-19-associated hospitalizations and medically-
Nevena Vicic   +9 more
doaj   +1 more source

Replicating the real-world evidence methods available in human health to assess burden and outcomes for dogs with chronic kidney disease, their owners, and the veterinary healthcare system in the United States of America

open access: yesFrontiers in Veterinary Science
IntroductionChronic kidney disease (CKD) in canines is a progressive condition characterized by a gradual decline in kidney function. There are significant gaps in understanding how CKD is managed in canines and the full extent of its impact.
Andrea Wright   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy